| 摘要 |
The present invention relates to methods of treating a cancer and in particular, a B- cell derived cancer, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug, either alone, or in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens. |
| 申请人 |
THE JOHNS HOPKINS UNIVERSITY;BRODSKY, ROBERT;JONES, RICHARD, J.;AMBINDER, RICHARD, F. |
发明人 |
BRODSKY, ROBERT;JONES, RICHARD, J.;AMBINDER, RICHARD, F. |
